In supplemental analysis , the overall response rate ( LSAS score @ ) was @ % , including a significantly greater proportion of patients in the sertraline plus clonazepam group ( @ % ) compared with the sertraline plus placebo group responding ( @ % ; p = @ ) ; differences did not reach significance between venlafaxine and sertraline plus placebo or sertraline plus clonazepam .